Nasdaq
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- undated
- Valid until
- still holds
- Published
- no source on record carries a date
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals listed on: Nasdaq", undated. Claim clm_60E05C2B8B5C, https://asof.is/claim/clm_60E05C2B8B5C, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589.
APA
AsOf. (n.d.). Regeneron Pharmaceuticals listed on: Nasdaq (undated) [Record clm_60E05C2B8B5C]. Retrieved November 9, 2026, from https://asof.is/claim/clm_60E05C2B8B5C (source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589)
BibTeX
@misc{asof_clm_60E05C2B8B5C,
author = {AsOf},
title = {Regeneron Pharmaceuticals listed on: Nasdaq},
howpublished = {\url{https://asof.is/claim/clm_60E05C2B8B5C}},
note = {Claim clm\_60E05C2B8B5C, undated; source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany\&CIK=0000872589},
urldate = {2026-11-09}
}On the record
/claim/clm_60E05C2B8B5C.md/v1/claims/clm_60E05C2B8B5Csubmit a correction